Funded by NIH STTR/SBIR Program
- Awarded the NIH Small Business Technology Transfer (STTR) Phase 1 grant in 2017.
- Awarded the NIH SBIR Phase 2 grant in 2020.
About US
Hura Imaging is a medical imaging software company focusing on AI innovations for imaging guided treatment.
OUR MISSION
Improve the safety, efficiency, and quality of the medical imaging process, in particular for imaging-guided treatment.
HuraCTP® TECHNOLOGY
First and the only FDA cleared denoising software dedicated for CT perfusion (CTP), physics-based AI algorithm with superior performance for improving image quality .
EXAMPLE
Hura CTP® improves image quality of CTP images for all CT models, validated by rigorous multi-center study.
HuraASL® (CereFlow) TECHNOLOGY
First comprehensive commercial software dedicated for arterial spin labeling (ASL) perfusion MRI.
Supported by multiple studies and publications.
Supported by multiple studies and publications.
EXAMPLE
HuraASL®(CereFlow) report for multiparametric perfusion maps with auto-processing of multi-delay pCASL data.
HuraRT® (DV.Target) TECHNOLOGY
Top FDA approved deep learning (DL) product on the market. Results of years of original research in the DL algorithm. Superior performance for time saving and contouring results.
EXAMPLE
HuraRT (DV.Target) Full Body of OARs.
Our PUBLICATIONS
All PublicationsOur BENEFITS
Hura technologies will significantly improve the diagnostic imaging quality for patients with cardiovascular disease and stroke, dementia, cancer as well as pediatric patients.
Patients
Improve safety and reduce the use of radiation/ contrast agent
Clinicians
Improve diagnostic accuracy and efficiency for treatment planning
Payers
Reduce cost and improve healthcare service provision and quality
FDA & Strategic Acquires
Increase regulatory compliance, improve function and competitiveness of equipment to drive sales
NATIONAL INSTITUTE OF HEALTH
Our Timeline
Our Team
Danny JJ Wang, PhD, MSCE
Founder & Chairman
Dr. Wang is a world leading expert in medical imaging with over 20 years of experience. Dr. Wang also maintains longstanding R&D collaborations with large OEMs including Philips, Siemens, Samsung and Neusoft.
Jerry Liu, MS, MBA
Co-Founder & CEO
Mr. Liu has more than 20 years of experience in international business development, marketing, investment, M&A and strategy in the healthcare industry.
Marc Korczykowski, MB, MA
Co-Founder & Chief Commercial Officer
Mr. Korczykowski served as a Senior Advisor at Brookline Capital Markets in NY and Senior Director, Clinical Operations at a publicly traded Biotech Company. He has 15 years of experience advancing clinical diagnostics and drug discovery & development efforts.
Xin J. Qiao, MD, MS
Co-Founder & Chief Compliance Officer
10 years of Experience in Medical Imaging Software R&D
Jeffry Alger, PHD
Chief Technology Officer
Adjunct Professor of UCLA David Geffen School of Medicine
Narisu Bai, MS
Chief Scientist
10 years Medical Software Development
Fabien Scalzo, PhD
Senior AI Scientist
Associate Professor of Computer Sciences, Pepperdine University
Joy Peng, MS
Senior Product Manager
8 years Medical Software Development
our ADVISORY BOARD
David S. Liebeskind, MD
Scientific Advisor and Consultant
Director of the UCLA Stroke Center
Professor of Neurology
UCLA Department of Neurology
Director, UCLA Stroke Center
Director, Neurovascular Imaging Research Core
An Liu, PhD
Medical Advisor
Clinical Professor, Department of Radiation Oncology. Clinical Professor and Director, Division of Radiation Physics, City of Hope
Hee Kwon Song, PhD
Chief Scientist
Associate Professor of Radiologic Science at University of Pennsylvania
John Detre, MD
Chief Medical Advisor
Director at Center for Functional NeuroImaging. Professor of Neurology & Radiology at University of Pennsylvania
Michael McNitt-Gray, PhD
Chief Science Advisor
Member of Science Advisory Board
Professor of Radiology; Director of Physics & Biology in Medicine Graduate Program; UCLA David Geffen School of Medicine
Brian Walsh, MS, MBA
Chief Commercial Advisor
Chief Commercial Advisor
& National Institute of Health Advisor
SIGNIFICANT INNOVATION IN CANCER CARE
Our Partners
